0.50
Allogene Therapeutics, Inc.
Metrics score locked — part of Premium
FY23
FY23
FY23
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
billions USD
FY23:
FY23:
0.47
FY23:
0.46
FY24:
0.30
FY25:
0.26
(positive)
Change from FY23 to FY25
billions USD
FY23:
0.27
FY23:
0.24
FY23:
0.18
FY24:
0.25
FY25:
0.16
Total assets
Change from FY23 to FY25
billions USD
FY23:
0.77
FY23:
0.71
FY23:
0.64
FY24:
0.55
FY25:
0.42
Liabilities & Equity
(negative)
Change from FY23 to FY25
billions USD
FY23:
0.05
FY23:
0.04
FY23:
0.04
FY24:
0.04
FY25:
0.03
(negative)
Change from FY23 to FY25
billions USD
FY23:
0.10
FY23:
0.10
FY23:
0.09
FY24:
0.09
FY25:
0.09
(positive)
Change from FY23 to FY25
billions USD
FY23:
0.62
FY23:
0.58
FY23:
0.51
FY24:
0.42
FY25:
0.29
Total liabilities & equity
Change from FY23 to FY25
billions USD
FY23:
0.77
FY23:
0.71
FY23:
0.64
FY24:
0.55
FY25:
0.42
All amounts in billions USD